References
- Thompson PM , HayashiKM, de ZubicarayGet al. Dynamics of gray matter loss in Alzheimer‘s disease. J. Neurosci.23(3), 994–1005 (2003).
- Fischl B , SalatDH, BusaEet al. Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron33(3), 341–355 (2002).
- Buckner RL , SnyderAZ, ShannonBJet al. Molecular, structural, and functional characterization of Alzheimer‘s disease: evidence for a relationship between default activity, amyloid, and memory. J. Neurosci.25(34), 7709–7717 (2005).
- Whitwell JL , JackCR, SenjemMLet al. MRI correlates of protein deposition and disease severity in postmortem frontotemporal lobar degeneration. Neurodegener. Dis.6, 106–117 (2009).
- Pacheco C , AguayoLG, OpazoC. An extracellular mechanism that can explain the neurotoxic effects of α-synuclein aggregates in the brain. Front Physiol.3, 297 (2012).
- Seeley WW , CrawfordRK, ZhouJ, MillerBL, GreiciusMD. Neurodegenerative diseases target large-scale human brain networks. Neuron62(1), 42–52 (2009).
- Saxena S , CaroniP. Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration. Neuron71(1), 35–48 (2011).
- Braak H , Del Tredici K, Schultz C, Braak E. Vulnerability of select neuronal types to Alzheimer‘s disease. Ann. NY Acad. Sci.924, 53–61 (2000).
- Englund E , BrunA, AllingC. White matter changes in dementia of Alzheimer‘s type. Biochemical and neuropathological correlates. Brain111(Pt 6), 1425–1439 (1988).
- Villain N , DesgrangesB, ViaderFet al. Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer‘s disease. J. Neurosci.28(24), 6174–6181 (2008).
- Frost B , DiamondMI. Prion-like mechanisms in neurodegenerative diseases. Nat. Rev. Neurosci.11(3), 155–159 (2010).
- Palop JJ , ChinJ, MuckeL. A network dysfunction perspective on neurodegenerative diseases. Nature443(7113), 768–773 (2006).
- Liu L , DrouetV, WuJWet al. Trans-synaptic spread of tau pathology in vivo. PLoS ONE7(2), e31302 (2012).
- Frost B , OlleschJ, WilleH, DiamondMI. Conformational diversity of wild-type tau fibrils specified by templated conformation change. J. Biol. Chem.284(6), 3546–3551 (2009).
- Raj A , KuceyeskiA, WeinerM. A network diffusion model of disease progression in dementia. Neuron73(6), 1204–1215 (2012).
- Barreda JL , ZhouHX. A solvable model for the diffusion and reaction of neurotransmitters in a synaptic junction. BMC Biophys.4, 5 (2011).
- Lo CY , WangPN, ChouKHet al. Diffusion tensor tractography reveals abnormal topological organization in structural cortical networks in Alzheimer‘s disease. J. Neurosci.30(50), 16876–16885 (2010).
- Hardy J . Expression of normal sequence pathogenic proteins for neurodegenerative disease contributes to disease risk: ‘permissive templating‘ as a general mechanism underlying neurodegeneration. Biochem. Soc. Trans.33(Pt 4), 578–581 (2005).
- Rabinovici GD , FurstAJ, AlkalayAet al. Increased metabolic vulnerability in early-onset Alzheimer‘s disease is not related to amyloid burden. Brain133(Pt 2), 512–528 (2010).
- Pereira JMS , WilliamsGB, Acosta-CabroneroJet al. Atrophy patterns in histologic vs clinical groupings of frontotemporal lobar degeneration. Neurology72(19), 1653–1660 (2009).
- Rabinovici GD , JagustWJ. Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo. Behav. Neurol.21(1), 117–128 (2009).
- Zhou J , GennatasED, KramerJH, MillerBL, SeeleyWW. Predicting regional neurodegeneration from the healthy brain functional connectome. Neuron73(6), 1216–1227 (2012).